Optimal therapy recommendations for the prescribing and use of blood glucose test strips. Canadian Agency for Drugs and Technologies in Health. NGC:007750

Publication Details

Author(s):

• AHRQ (US) - Agency for Healthcare Research and Quality

Country(ies) of application:

• Canada

Language(s):

• English

Type of Publication:

Guideline Clearing Report

Primary Contact:

Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Management

Publication Status:

Published

Date of publication:

Jul 01, 2009

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Endocrine System Diseases (C19)
  • Diabetes Mellitus (C19.246)
    • Diabetes Mellitus, Type II (C19.246.300)
    • Diabetes Mellitus, Type I (C19.246.267)
• Diagnosis (E01)
  • Diagnostic Techniques and Procedures (E01.370)
• Nutritional and Metabolic Diseases (C18)
  • Metabolic Diseases (C18.452)
    • Glucose Metabolism Disorders (C18.452.394)

Guideline key questions